Irritants - Riot Control Agents

Back

Practice Essentials

Riot control agents (and their abbreviations) discussed in this article include tear gas (CS); chloroacetophenone (CN); chloroacetophenone in chloroform (CNC); bromobenzenecyanide (CA); dibenz-(b,f)-1,4-oxazepine (CR); CN, carbon tetrachloride, and benzene (CNB); and chloropicrin (PS).

Riot control agents are chemical compounds that temporarily disable victims due to their noxious contamination of skin, eyes, mucous membranes, and respiratory tract. They are not meant to kill, but to render a victim momentarity helpless. However, in certain circumstances, they can cause long-term medical sequelae, including death.[1, 2]

No antidotes exist. Treatment is supportive and begins with removal from the site of exposure. Patients with significant exposures require decontamination.[1, 3, 4, 5, 6]  

 

 

Background

The sole purpose of irritants (also known as tear gas, riot control agents, and lachrymators) is to produce immediate dermatological, respiratory, and ocular discomfort in order to render the victim incapable of fighting or resisting. Police forces use them for crowd control, and military forces currently use them mainly for training. These agents were used before World War I, and in that war, they were the first chemical agents used—well before the better-known chlorine, phosgene, and mustard gas. The United States used them during the Vietnam War to deny tunnel access to its enemies.[1]

The United States excludes these agents from the 1925 Geneva Convention banning other chemical and biological weapons. Dispersal is allowed in specific US military operations but only by presidential order.

Tear gas (CS) and chloroacetophenone (CN) are by far the most important pulmonary irritants. The two-letter codes designating these types of compounds were assigned by the North Atlantic Treaty Organization (NATO); the abbreviation for tear gas reflects the fact that it was first synthesized by Corson and Stoughton.[7]

CN was the primary pulmonary irritant after World War I until the development of CS in 1928. CS was found to be more potent (10 times more potent as a lachrymator than CN) but less toxic. In approximately 1959, CS replaced CN as the principal military and law enforcement riot control agent.

CS is the familiar tear gas most often used by police for crowd control (eg, the police in the United Kingdom have used CS as an incapacitant for the past decade). CN has been available as Mace, a product that had been used for personal protection. Capsaicin, or pepper spray, has to some extent replaced CN as a personal protective agent, with less dangerous effects.[8]  

Although CS and CN are the most important agents in this class, several others require mention. Chloropicrin (PS) and bromobenzenecyanide (CA) were developed before World War I. Both largely have been replaced, as they were too lethal for their intended effects but not lethal enough to compete with the more effective blistering and nerve agents. PS is still seen occasionally as a soil sterilant, fumigant or grain disinfectant.[3, 6]

Attempts to make CN more effective resulted in the creation of CNB (CN, carbon tetrachloride, and benzene), chloroacetophenone in chloroform (CNC), and CNS (CN, chloroform, and PS). However, CS proved more effective and less toxic than any of the CN series and largely has replaced them. While the clinical effects of a CS spray may last for days, subjects sprayed with CS have shown no convincing physical evidence of pathology for up to 10 months afterward.[9]

Dibenz-(b,f)-1,4-oxazepine (CR) is a more recent tear gas, first synthesized in 1962. It reportedly is more potent and less toxic than CS. Part of its high safety profile is due to its low volatility, which minimizes its effects deep in the pulmonary system. However, it is still is not used widely. Pepper spray, or oleoresin capsicum (OC), is also considered a riot control agent. A 1% solution is sold commercially to the public, but 10% solutions exist. OC causes the release of a neuropeptide (substance P) that causes pain and inflammation. A recent review states that the neurogenic inflammation caused by capsaicinoid in the pepper spray is the cause of the compound's irritative effects.[10] However, at high concentrations and with prolonged exposure, fatalities with capsaicinoids have been reported.[11]  

The possibility of secondary contamination is very real. In one incident, CS was used to flush out possible stowaways on a cargo vehicle. When the cargo was finally delivered to 16 stores within Scotland, 21 workers experienced itching and running eyes, rhinorrhea, a burning sensation on the face and hands, and a burning throat.[12] In case studies, secondary exposures have also affected emergency department personnel and anesthetists.[2]

Onset of symptoms occurs in seconds to several minutes after exposure to pulmonary irritants. Most cases are brief and self-limited, and most persons do not seek medical care. Without continuing exposure, symptoms typically resolve spontaneously in 15-30 minutes, and most persons do not seek medical care. However, serious effects, including death, have been reported.[3, 4, 5, 6] See Presentation.

 

Pathophysiology

Riot control agents are solids with low vapor pressures that are dispersed as fine particles or in solution. CS and CN are SN2 alkylating agents and react at nucleophilic sites. Although the mechanism is presently unclear, injuries caused by this class of agents may be caused by inactivation of sulfhydryl-containing enzymes such as lactic dehydrogenase and a specific coenzyme in the pyruvate decarboxylase system (disulfhydryl form of lipoic acid).[2]

Research has indicated that these agents are extremely potent activators of the body's TRPA1 (a family of transient receptor potential ion channel) receptors (ie, mechanical stress sensors).[1, 13] Since anti‐inflammatory and analgesic effects have been observed for TRPA1 inhibitors in multiple models of chemical injury and inflammation, it is possible that TRPA1 inhibitors could alleviate at least some of the tear gas–induced effects. The conclusion of clinical trials using TRPA1 inhibitors in diabetic neuropathic patients is eagerly awaited with the hope that more advanced inhibitors will be made available for testing in other conditions, including irritant and tear gas agent exposures.[14]

Epidemiology

No race- or sex-related susceptibility to pulmonary irritants exists. Chemical irritants, especially those deployed in aerosolized forms, are inherently indiscriminate and can affect not only the intended targets but also peaceful demonstrators, bystanders, nearby communities and residences, and law enforcement officers themselves. The majority of people injured are young adults, consistent with typical protest demographics. Children are more vulnerable to severe injuries from chemical toxicity. The elderly and those with chronic diseases are also prone to worse outcomes.[15]

Prognosis

The prognosis for patients with irritant exposure is excellent. The few reported dangerous effects occur rapidly.

Short-term effects of pulmonary irritants predominate. Fatalities, albeit few, have occurred at high concentrations and with prolonged exposure.[15]   In fact, the risk of death is directly related to the agent, the concentration of the agent, the duration of exposure, the proximity to the source, and location (ie, indoors vs. outdoors).[1]

A systematic review of CS that included 90 cases of CS exposure reported the following distribution of effects[2] :

Complications include the following:

A 2015 review of 10 RCA-related deaths found that RCAs were the sole cause of death in three cases, a secondary cause in three (asthma, asphyxia), and contributory in four. Pepper spray (oleoresin capsicum; OC) was the RCA involved in eight of the cases, while chloroacetophenone (CN) and tear gas (CS) caused one apiece.[16]

Different types of symptoms tend to vary in their duration. A systematic review of CS exposure found the following typical durations[2] :

In rare cases, particular reactions may persist for much longer than usual (eg, dermatitis lasting for several months).

Patient Education

Upon exposure to a riot control agent, the key steps are to remove oneself from the site of dissemination as quickly as possible—the mantra is to go "uphill, upwind, upstream—and then begin the process of decontamination, should sufficent material remain in contact with eyes, skin, and clothes.

Symptoms caused by a riot control agent should subside within half an hour. Persistence of effects beyond that time suggests that the agent may, in fact, not be a relatively harmless RCA, but a more toxic substance such as lewisite or phosgene, in which case, thorough decontamination is necessary.

For patient education information, see Chemical Warfare and Personal Protective Equipment.

History

The timing of symptom onset after exposure to tear gas (CS) varies, depending on the duration of exposure and the organ system involved. With dermal effects, for example, erythema may develop within a few  minutes, whereas acute generalized exanthematous pustulosis may have a latency period of 1-2 weeks. Similarly, respiratory effects can occur immediately (eg, cough) or develop after about 3 weeks (eg, laryngeal obstruction).[2]  

Most cases are self-limited, lasting 15-30 minutes after clothing is removed and the person is in an open space.[1] Reconsider the diagnosis of riot control agents if symptoms persist longer than 30 minutes. However, in one study, the majority of subjects who were directly sprayed with CS in the face still had respiratory and oral symptoms after 1 hour.[9]   

Typically, exposed persons feel a burning sensation in the eyes, nose, mouth, and even airway. The eye is the most sensitive organ involved and is the most immediately and severely affected of all the target organs. Eye involvement may include the following:

Other manifestations are as follows:

Skin contact with a riot control agent results in erythema, tingling, and burning. Blistering may also occur after exposure to higher concentrations. Skin involvement tends to be more severe with CN, and may include irritation, bulla formation, and subcutaneous edema.[17] Dermal manifestations develop within minutes of exposure and last up to 1 hour after termination of exposure.

More severe skin injuries can occur in hot, humid environments with heavily sweating or wet patients or with prolonged or close-range exposures. First- or second-degree burns and delayed allergic contact dermatitis may be seen, especially with exposure to CN and CS.

Police and bystanders may be unintended victims of riot control agents. In a study by Watson and Rycroft, six police officers and one bystander developed contact dermatitis, leukoderma, exacerbation of seborrheic dermatitis, and aggravation of rosacea following exposure to CS.[18]

Serious effects, including death, have been reported. CN has accounted for five deaths due to pulmonary injury and/or asphyxia. A case report involved a 4-week-old infant who accidentally received a discharge of pepper spray (OC), which immediately led to respiratory distress, followed by apnea. The infant was resuscitated and ultimately recovered after much intensive care, including extracorporeal membrane oxygenation (ECMO).[19]

Severe effects (eg, pulmonary edema, chemical pneumonitis) usually occur only with prolonged exposure in an enclosed space. Such exposures can damage the respiratory tree. Upper airway mucosal necrosis and pulmonary edema have been reported.

Some studies have suggested that CS may be converted into cyanide in the peripheral tissues. However, the risk of cyanide toxicity seems to be minimal.[20]

One animal study has demonstrated no adverse effects of CS during pregnancy.[20]  

Unintentional oral ingestions can occur, specifically in children. Abdominal cramps and diarrhea are common, but the ultimate course usually is uneventful. The lethal dose in one half of the exposed population (LD50) in animals is 200 mg/kg, which is an amount unlikely to be ingested.

Other gases irritating to the mucous membranes and respiratory system (eg, lewisite, phosgene oxime) may be confused with pulmonary irritants. Features that help with distinguishing these include the following:

Long-term effects, usually as a result of prolonged exposure, can include ophthalmological complications such as cataracts, glaucoma, and blindness as well as pulmonary deterioration leading to respiratory failure.[6]

Physical Examination

Physical findings in patients exposed to riot control irritants are as follows[1, 3, 4, 5, 6, 10] :

Severity of manifestations varies with the age of the victim, comorbid factors, and duration of exposure.

Complications

 Short-term complications include the following[1, 3, 6]

Long-term include the following[1, 3, 6] :

Approach Considerations

Clinicians should don appropriate personal protective equipment (PPE) before triaging and assessing patients assumed to be contaminated with a riot control agent (RCA). Victims who have RCAs on clothes and exposed body parts require decontamination as a first step. 

Diagnosis of pulmonary irritant exposure is based on clinical findings. However, the following may provide useful information in some cases:

Laboratory Studies

Laboratory studies are not indicated unless an exposure to a RCA was prolonged or the RCA-exposure diagnosis is in doubt.

Consider the following:

 

Other Tests

Consider the following:

 

Procedures

Consider the following:

Approach Considerations

No antidote to riot control agents (RCAs) exists, so treatment is symptomatic and supportive. Treatment measures for RCA exposure include the following:

Prehospital Care

Most people exposed to irritants do not seek medical care, and effects are self-limited. When persons seek care, first withdraw them from exposure. Responders should wear appropriate personal protective equipment (PPE). Decontamination should then proceed as follows:

Emergency Department Care

Initiate or continue care in the emergency department (ED) as follows:

Most patients with irritant exposure can safely be discharged from the ED, as the few reported dangerous effects occur rapidly.The rare patient with significant respiratory damage may require oxygen supplementation, aggressive bronchodilator therapy (if bronchospasm is present), and admission to the hospital, possibly a critical care unit.

Characteristically, hospital admission for extended medical care is not indicated.  Should hospitalization be required, consider alternative diagnoses.

Medical Care

Victims should be made aware that initial symptoms may be minimal or that there may even be a latent period.  Should any clinical deterioration occur the patient should be re-evaluated.

Medical follow-up is indicated for a minority of patients, including those with any of the following:

Consultations

Consultations with one or more of the following may be indicated:

Diet

No restrictions.

Activity

As tolerated.

Long-Term Monitoring

Consider the following in long-term monitoring:

Medication Summary

In general, only decontamination with water is necessary when a patient's skin has been grossly exposed to riot control agents. Bronchodilators, analgesics, and pulmonary support may be needed, depending upon the severity of injury.

Diphoterine and vegetable oil  have chelating and amphoteric properties that show some promise in managing dermal exposures, but more studies are required to prove efficacy.[22]

Antibiotics may be reserved for dermal and pulmonary complications.  An antiobitic ointment may be helpful with ocular involvment.

Analgesics for pain, preferably non-steroidal agents;

Albuterol 0.5% (Proventil, Ventolin)

Clinical Context:  Beta-agonist for bronchospasm refractory to epinephrine. Relaxes bronchial smooth muscle by action on beta 2-receptors with little effect on cardiac muscle contractility.

Class Summary

Use only for patients with evidence of significant bronchospasm after exposure.

Ibuprofen (Motrin, Ibuprin)

Clinical Context:  Acts as an analgesic, antipyretic, and anti-inflammatory agent.

Class Summary

NSAIDs have analgesic, anti-inflammatory, and antipyretic activities. Their mechanism of action is not known, but they may inhibit cyclooxygenase activity and prostaglandin synthesis. Other mechanisms, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell-membrane functions, may exist as well.

Oxycodone/acetaminophen (Percocet, Roxicet, Roxilox)

Clinical Context:  Drug combination indicated for relief of moderate to severe pain.

Class Summary

Pain control is essential to quality patient care. Analgesics ensure patient comfort, promote pulmonary toilet, and have sedating properties, which are beneficial for patients who have sustained trauma or injuries.

Gentamicin 0.3 % solution (Genoptic, Ocu-Mycin)

Clinical Context:  Indicated for corneal abrasions. Aminoglycoside antibiotic used for gram-negative bacterial coverage.

Erythromycin ophthalmic (E-Mycin)

Clinical Context:  Indicated for corneal abrasions and infections caused by susceptible strains of microorganisms and for prevention of corneal and conjunctival infections.

Class Summary

Therapy must cover all likely pathogens in the context of the clinical setting.

Author

Paul P Rega, MD, FACEP, Assistant Professor, Department of Public Health and Preventive Medicine, Assistant Professor, Emergency Medicine Residency Program, Department of Emergency Medicine, The University of Toledo College of Medicine; Director of Emergency Medicine Education and Disaster Management, OMNI Health Services

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Zygmunt F Dembek, PhD, MPH, MS, LHD, Associate Professor, Department of Military and Emergency Medicine, Adjunct Assistant Professor, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Mark Keim, MD, Founder, DisasterDoc, LLC; Adjunct Professor, Emory University Rollins School of Public Health; Adjunct Professor, Harvard Affiliated Disaster Medicine Fellowship

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors, Eric Mowatt-Larssen, MD, and David P Sole, DO, to the development and writing of this article.

References

  1. Schep LJ, Slaughter RJ, McBride DI. Riot Control Agents: The tear gases CN, CS, and OC - a medical review. J R Army Med Corp. 6/2015. 161:94-99. [View Abstract]
  2. Dimitroglou Y, Rachiotis G, Hadjichristodoulou C. Exposure to the riot control agent CS and potential health effects: a systematic review of the evidence. Int J Environ Res Public Health. 2015 Jan 27. 12 (2):1397-411. [View Abstract]
  3. Centers for Disease Control and Prevention. Riot Control Agent Poisonings; Toxic Syndrome Description. CDC.gov. Available at https://emergency.cdc.gov/agent/riotcontrol/agentpoisoning.asp. November 18, 2015; Accessed: May 24, 2018.
  4. The National Institute for Occupational Safety and Health. Chloroacetophenone (CN): Riot Control/Tear Agent. CDC.gov. Available at https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750033.html. November 9, 2017; Accessed: April 11, 2018.
  5. National Institute for Occupational Safety and Health. Chloropicrin (PS): Lung Damaging Agent. CDC.gov. Available at https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750034.html. November 9, 2017; Accessed: April 11, 2018.
  6. Centers for Disease Control and Prevention. Facts About Riot Control Agents. CDC.gov. Available at https://emergency.cdc.gov/agent/riotcontrol/factsheet.asp. March 21, 2013; Accessed: April 11, 2018.
  7. Committee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council. Tear Gas (CS). 2014 Mar 21. [View Abstract]
  8. [Guideline] Warden CR. Respiratory agents: irritant gases, riot control agents, incapacitants, and caustics. Crit Care Clin. 2005 Oct. 21(4):719-37, vi. [View Abstract]
  9. Karagama YG, Newton JR, Newbegin CJ. Short-term and long-term physical effects of exposure to CS spray. J R Soc Med. 2003 Apr. 96(4):172-4. [View Abstract]
  10. Yeung MF, Tang WY. Clinicopathological effects of pepper (oleoresin capsicum) spray. Hong Kong Med J. 2015 Dec. 21 (6):542-52. [View Abstract]
  11. Pesonen M, Vahakangas K, Halme M, et al. Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers. Front Pharmacol. 2010. 1:140. [View Abstract]
  12. Hankin SM, Ramsay CN. Investigation of accidental secondary exposure to CS agent. Clin Toxicol (Phila). 2007 May. 45(4):409-11. [View Abstract]
  13. Brone B, Peeters PJ, Marrannes R, et al. Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor. Toxicol Appl Pharmacol. Sep 2008. 231(2):150-6. [View Abstract]
  14. Rothenberg C, Achanta S, Svendsen ER, Jordt SE. Tear gas: an epidemiological and mechanistic reassessment. Ann N Y Acad Sci. 2016 Aug. 1378 (1):96-107. [View Abstract]
  15. Haar RJ, Iacopino V, Ranadive N, Weiser SD, Dandu M. Health impacts of chemical irritants used for crowd control: a systematic review of the injuries and deaths caused by tear gas and pepper spray. BMC Public Health. 2017 Oct 19. 17 (1):831. [View Abstract]
  16. Toprak S, Ersoy G, Hart J, Clevestig P. The pathology of lethal exposure to the riot control agents: Towards a forensic-based methodology for determining misuse. J Forensic Legal Med. 2015. 29:36-42. [View Abstract]
  17. Schep LJ, Slaughter RJ, McBride DI. Riot control agents: the tear gases CN, CS and OC-a medical review. J R Army Med Corps. 2015 Jun. 161 (2):94-9. [View Abstract]
  18. Watson K, Rycroft R. Unintended cutaneous reactions to CS spray. Contact Dermatitis. 2005 Jul. 53(1):9-13. [View Abstract]
  19. Billmire DF, Vinocur C, Ginda M, Robinson NB, Panitch H, Friss H. Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenation. Pediatrics. 1996 Nov. 98(5):961-3. [View Abstract]
  20. Shen S. Riot-control agent attack. Ciottone GR, Anderson PD, Auf Der Heide E, Darling RG, Jacoby I, Noji E, Suner S, eds. Disaster Medicine. 3rd ed. Philadelphia, PA: Mosby/Elsevier; 2006. Chap 98, 593-595.
  21. Stopyra JP, Winslow JE 3rd, Johnson JC 3rd, Hill KD, Bozeman WP. Baby Shampoo to Relieve the Discomfort of Tear Gas and Pepper Spray Exposure: A Randomized Controlled Trial. West J Emerg Med. 2018 Mar. 19 (2):294-300. [View Abstract]
  22. Pitschmann V. Overall view of chemical and biochemical weapons. Toxins (Basel). 2014 Jun 4. 6 (6):1761-84. [View Abstract]